Explore Series B financing, the second investment stage where established startups attract higher-value funding from private ...
Life science researchers use serial dilutions for a number of purposes, including estimating specific concentrations of a target of interest, determining optimal working conditions for a protocol, or ...
Incannex Healthcare cancels 172 million Series A Warrants, reducing potential share dilution and strengthening capital structure ahead of key trial data. Incannex is eliminating up to 347.2 million ...
MELBOURNE, Australia and NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company advancing combination drug therapies for ...